Page 10 - Presection News Today

Adjuvant pembrolizumab significantly improved disease-free survival (DFS) compared to placebo in patients who had undergone complete resection, according to findings from the phase 3 PEARLS study.

Is thejudge found might file against them. bottom line is the judge found that it was ambiguous in terms of the resection of the settlement. and that prince andrew who is not specifically named as someone who was to be released from any additional claims or claims prior to that date of settlement that he is not covered by that release. so that means that the lawsuit by virginia against prince andrew can continue. that also means thejudge was saying andrew can continue. that also means the judge ...

Neuroendoscopic treatment of brain abscess is associated with definite curative effects and rapid postoperative recovery.

The new findings may provide some reassurance to oncologists about patients preference for surgery. The study was published as a preprint and has not yet been peer reviewed.

A downside to treating appendicitis with antibiotics is that appendiceal cancer can be missed.

Perioperative immunotherapy appears to be safe in the setting of resectable hepatocellular carcinoma, according to findings from an open-label phase 2 clinical trial.

Complex surgery is much more likely for advanced ovarian cancer in women with mesenchymal tumors and complex preoperative CT findings.

Although circulating tumor DNA (ctDNA) tests are already marketed for this use, they provide no advantage over standard approaches, concludes a new review.

Long-term results from the Dutch PREOPANC trial confirm that neoadjuvant chemoradiotherapy conveys a survival advantage to patients with resectable and borderline resectable pancreatic cancer.

Data from nearly 100,000 US patients with small, differentiated thyroid cancers showed surgery produced significantly better overall survival compared with surveillance without immediate surgery.